N/A
Completed N=60
Music Therapy in Sickle Cell Pain Mixed Methods Study
Source: ClinicalTrials.gov NCT02270060 ↗Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Jul 2019
Primary outcomePrimary: Change (Post - Pre) From Baseline in Visual Analog Scale of Pain Intensity (VASPI) of Memorial Pain Assessment Card — -1.92; -1.92; -1.19 score on a scale
Summary
The purpose of this research study is to:
1. Investigate the effects of a single 20-minute music therapy intervention with a music therapist on the pain intensity, pain relief, and mood of adult patients with sickle cell disease as compared to:
1. Adult patients with SCD who listen to their preferred music for 20 minutes without the presence of a music therapist (music listening group)
2. Adult patients with SCD who receive standard care alone (control group)
2. Determine the feasibility (delivery, acceptability, and usefulness) of the music therapy intervention for pain management
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change (Post - Pre) From Baseline in Visual Analog Scale of Pain Intensity (VASPI) of Memorial Pain Assessment Card |
-1.92; -1.92; -1.19 | — |
| SECONDARY Change (Post - Pre) From Baseline in Visual Analog Scale of Pain Relief (VASPR) of Memorial Pain Assessment Card |
2.05; .86; .45 | — |
| SECONDARY Change (Post- Pre) From Baseline in Visual Analog Scale of Mood (VASMOOD) of Memorial Pain Assessment Card |
2.33; .96; .74 | — |
| SECONDARY Change (Post - Pre) From Baseline in Tursky Scale of Memorial Pain Assessment Card |
-0.80; -0.35; -0.50 | — |
| SECONDARY Length of Stay in Minutes |
272.95; 286.80; 287.45 | — |
| SECONDARY Amount of Hydromorphone |
10.30; 8.10; 10.00 | — |
| SECONDARY Change (Post - Pre) From Baseline in Numeric Pain Rating (NPR) |
-2.70; -2.95; -3.10 | — |
Eligibility Criteria
Inclusion Criteria
- Subjects who have a diagnosis of sickle cell disease (HbSS, HbSC, HbSbeta+thal, or HbSbeta0thal)
- 18 years or older
- Able to speak and understand English
Exclusion Criteria
- Patients who have significant hearing impairments and/or significant visual impairments that have not been corrected
Data sourced from ClinicalTrials.gov (NCT02270060). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.